InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures SRC Approval to Advance Acclaim-1 Trial to Higher Dose
Aug 15, 2022
Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company today announced that the Safety Review Committee (“SRC”) has approved continuation of the Acclaim-1 phase 1/2 clinical trial of REQORSA(TM) in combination with Tagrisso(R) (osimertinib) to treat late-stage non-small cell lung cancer (“NSCLC”) following a review of the first cohort of patients in the phase 1 portion of the trial. In 2020, Genprex received U.S. Food and Drug Administration’s (“FDA”) Fast Track Designation for treatment of the Acclaim-1 patient population. “The SRC approval to advance Acclaim-1 to the higher dose in the second cohort of patients is an important milestone that further supports REQORSA’s safety profile and brings us one step closer to bringing this potentially ground-breaking gene therapy approach to treating NSCLC to the patients who need it most,” said Mark Berger, M.D., chief medical officer of Genprex. “Enrollment in Acclaim-1 remains on track to complete the phase 1 portion of the study by year end.”
To view the full press release, visit https://ibn.fm/HJ5NI
About Genprex Inc.
Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its unique, proprietary, non-viral ONCOPREX(R) Nanoparticle Delivery System, which the company believes is the first systemic gene therapy delivery platform used for cancer in humans. ONCOPREX encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is administered intravenously, where it is then taken up by tumor cells that express proteins that are deficient. The company’s lead product candidate, REQORSA(TM) (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). REQORSA has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. In 2020, the U.S. Food and Drug Administration (“FDA”) granted Fast Track Designation for REQORSA for NSCLC in combination therapy with AstraZeneca’s Tagrisso(R) (osimertinib) for patients with EFGR mutations whose tumors progressed after treatment with Tagrisso. In 2021, the FDA granted Fast Track Designation for REQORSA for NSCLC in combination therapy with Merck & Co’s Keytruda(R) (pembrolizumab) for patients whose disease progressed after treatment with Keytruda. For more information, visit the company’s web site at www.Genprex.com.
NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.
Samsung, SK hynix shareholder return policies in focus ahead of Q3 earnings
Shareholder return policies of Samsung Electronics and SK hynix are gaining market attention ahead of their announcements for third-quarter earnings, as investors see them as a key way to address the mismatch between the chipmakers' record-breaking profits and their sluggish share prices. Samsung Electronics is set to announce its three-month financial results during its earnings call on Thursday, while SK hynix said it will announce its results on its earnings call on Wednesday. Earnings are expected to be exceptionally strong, as surging demand for memory chips and continued supply bottlenecks have driven up average selling prices across the memory chip market. In its earnings guidance released Oct. 8, Samsung Electronics estimated third-quarter revenue of 195 trillion won ($146.96 billion) and operating profit of 107.4 trillion won. If realized, the company will become the first Korean company to surpass 100 trillion won in quarterly operating profit. SK hynix is expected to post 98.23 trillion won in revenue and 76.96 trillion won in operating profit during the same period, according
Early user reports of iPhone Duo mishaps see cracked screens and faulty pixels
Users report that inner displays become damaged after a few folds, with
Two part-timers and one AI orchestrator: Inside a Dubai conference on “The Breaking Point” — Part 1
Most conferences are built the same way. A committee brainstorms a theme, a team chases speakers, a designer lays out a program, and everyone hopes the real value happens in the corridors. Three days in Dubai this October worked differently. The operating model was deliberately lean: two people shaping the ideas and running the room, […] The post Two part-timers and one AI orchestrator: Inside a Dubai conference on “The Breaking Point” — Part 1 appeared first on e27.
Ailytics bags US$7.4M Series A to make old CCTV cameras earn their keep
Most industrial CCTV cameras lead a thankless life. They record everything, are watched by almost no one, and only become important after something has gone wrong, when their footage turns into evidence rather than prevention. Singapore-based Ailytics has built a business on reversing that order. The vision AI startup has raised US$7.4 million in an […] The post Ailytics bags US$7.4M Series A to make old CCTV cameras earn their keep appeared first on e27.
Youth brain drain: A hidden threat in Indonesia’s agriculture sector
Indonesia is losing its farmers. According to Statistics Indonesia (BPS), the number of farmers dropped from 31.7 million in 2013 to 29.3 million in 2023. That is a drop of about 7.5 per cent in ten years. Many of them moved to other jobs, such as construction work, factory work, or selling in the market, […] The post Youth brain drain: A hidden threat in Indonesia’s agriculture sector appeared first on e27.
Alibaba Cloud founder on how AI can unlock human potential
Long before artificial intelligence became the next big thing in the tech industry, Wang Jian was crafting the foundational infrastructure that would eventually power it. In 2008, he joined Alibaba Group Holding – owner of the South China Morning Post – as chief architect and founded Alibaba Cloud in 2009, convincing the company’s leadership to invest heavily in building a cloud computing infrastructure from scratch. Today, Wang’s purview has expanded considerably. As an academician at the...
Japan’s innovation problem is execution, and Southeast Asian startups are built for it
Japan has industrial expertise and established corporate networks. Southeast Asia has startups building digital products for fast-changing markets. The opportunity lies in connecting these strengths, not simply exporting Japanese technology or selling into Southeast Asia. Japan’s next innovation challenge is about execution Japan has long been associated with advanced manufacturing, engineering excellence, and globally competitive […] The post Japan’s innovation problem is execution, and Southeast Asian startups are built for it appeared first on e27.
Founders are buying gold, not Lamborghinis, after the exit
A running joke in Singapore’s startup circles holds that a founder’s net worth exists only in two places: the cap table and the LinkedIn bio. For most of Southeast Asia’s entrepreneurs, the joke still lands. IPO windows open and slam shut, trade sales are thin on the ground, and secondary sales have become the region’s […] The post Founders are buying gold, not Lamborghinis, after the exit appeared first on e27.
China shoots ahead on AI video models
While few dispute that China is narrowing the gap with the United States in developing artificial intelligence (AI) models, there is one area where Chinese firms are already the undisputed leaders: video. China has seen a proliferation of advanced generative AI video models – systems trained on visual data to generate or edit video content based on user inputs such as text prompts, images and audio. The country’s vast short-video ecosystems and looser copyright rules have helped give Chinese...
Thirty climate tech startups in Southeast Asia that would rather build than pledge
Southeast Asia has a talent for making climate pledges sound like wedding vows: grand, emotional and frequently broken. Net-zero deadlines stretch to 2050 and beyond, yet coal still dominates several national grids, petrol motorbikes still choke the cities and mangroves still vanish faster than ministers can name them. Into that gap has stepped a scrappy […] The post Thirty climate tech startups in Southeast Asia that would rather build than pledge appeared first on e27.
How a 39-store retail chain in Laos moved from Excel to AI agents
Until this summer, the morning numbers at LDC Import-Export Co., Ltd. were built by hand. LDC is a Lao distribution and retail group. It started in Vientiane in 2011, distributing local and imported goods, and its retail arm now runs 39 convenience stores across seven provinces, including Jiffy shops on PTT fuel forecourts and its […] The post How a 39-store retail chain in Laos moved from Excel to AI agents appeared first on e27.
Strong iPhone Duo demand reportedly prompts Apple to increase orders by 44%
The iPhone Duo reportedly saw stronger-than-expected pre-orders in several major markets, prompting a significant increase in production orders.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.